Sex steroid hormones and reproductive disorders: impact on women's health

scientific article published on August 2011

Sex steroid hormones and reproductive disorders: impact on women's health is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1177/1933719111405068
P698PubMed publication ID21795737
P5875ResearchGate publication ID51527287

P50authorPaul DevroeyQ7150251
Robert N. TaylorQ50063528
Felice PetragliaQ56628175
Paolo VercelliniQ57008851
Thomas D'HoogheQ92610651
Lone HummelshojQ94657080
B. C. J. M. FauserQ112562991
Vincenzo De LeoQ45452591
P2093author name stringPaul G Mermelstein
Joop S E Laven
Kelle H Moley
Hilary O D Critchley
Basil C Tarlatzis
Luca Gianaroli
Sarah L Berga
Susan Rubin
Angelique J Goverde
P2860cites workPolycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespanQ21245262
Medroxyprogesterone acetate antagonizes the effects of estrogen treatment on social and sexual behavior in female macaquesQ24542881
Clinical practice. Primary ovarian insufficiencyQ24653014
Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism riskQ28202563
Spatiotemporal coupling of focal extracellular matrix degradation and reconstruction in the menstrual human endometriumQ30875482
Analysis of multiple data sets reveals no association between the insulin gene variable number tandem repeat element and polycystic ovary syndrome or related traitsQ30982554
Preventing local regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 enhances angiogenesisQ33922773
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).Q34285382
Loci at chromosomes 13, 19 and 20 influence age at natural menopauseQ34398729
IMS updated recommendations on postmenopausal hormone therapyQ34626471
Vascular dysfunction and metabolic parameters in polycystic ovary syndromeQ46471315
Estradiol activates group I and II metabotropic glutamate receptor signaling, leading to opposing influences on cAMP response element-binding protein.Q46497183
Cognitive impairment associated with adjuvant therapy in breast cancerQ46647395
Quantitative expression of apoptosis-regulating genes in endometrium from women with and without endometriosisQ47586464
Disordered meiotic regulation of oocytes by duration of diabetes mellitus in BBdp rat.Q48777645
Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis.Q53541411
Polycystic Ovary SyndromeQ56092373
Maternal polycystic ovary syndrome may be associated with adverse pregnancy outcomesQ56989045
Developmental origin of polycystic ovary syndrome - a hypothesisQ34721288
Non-genomic actions of androgens.Q34727863
Consensus on infertility treatment related to polycystic ovary syndrome.Q34744664
Emerging role of genomics in endometriosis researchQ34953119
Genetics of ovarian disorders: polycystic ovary syndromeQ35668794
S-palmitoylation modulates estrogen receptor alpha localization and functions.Q36308079
Endometrium in PCOS: Implantation and predisposition to endocrine CA.Q36505888
Pregnancy complications in PCOS.Q36505905
A meta-analysis of pregnancy outcomes in women with polycystic ovary syndromeQ36557607
Plasma membrane estrogen receptorsQ36660250
Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome.Q36758555
Endometriosis: cost estimates and methodological perspectiveQ36856199
VEGF blockade inhibits angiogenesis and reepithelialization of endometriumQ36879461
Polycystic ovary syndrome and pregnancy outcome: red herring or red flag?Q36884181
Rapid actions of androgensQ36993488
Decreased oocyte-granulosa cell gap junction communication and connexin expression in a type 1 diabetic mouse modelQ37060666
Nervous system physiology regulated by membrane estrogen receptorsQ37143039
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force reportQ37308058
Maternal diabetes causes mitochondrial dysfunction and meiotic defects in murine oocytesQ37369790
Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.Q37412812
Polycystic ovary syndrome, obesity and reproductive implicationsQ37585306
Oestrogen and progesterone regulation of inflammatory processes in the human endometriumQ37672732
Obesity, pregnancy, inflammation, and vascular function.Q37705670
Metabolic impact of estrogen signalling through ERalpha and ERbetaQ37769774
Primary ovarian insufficiencyQ37779848
A botanical extract from channel flow inhibits cell proliferation, induces apoptosis, and suppresses CCL5 in human endometriotic stromal cellsQ39983603
Membrane androgen receptor activation induces apoptotic regression of human prostate cancer cells in vitro and in vivoQ40483359
Oestrogen receptor (ER)-alpha and ER-beta isoforms in normal endometrial and endometriosis-derived stromal cellsQ41674994
Sulindac suppresses nuclear factor-kappaB activation and RANTES gene and protein expression in endometrial stromal cells from women with endometriosisQ42483929
Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control studyQ43043857
Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese populationQ43271333
Widespread increases of cortical serotonin type 2A receptor availability after hormone therapy in euthymic postmenopausal womenQ44582007
Follicle-stimulating hormone receptor polymorphisms in women with normogonadotropic anovulatory infertilityQ44615923
Coexpression of fractalkine and its receptor in normal human endometrium and in endometrium from users of progestin-only contraception supports a role for fractalkine in leukocyte recruitment and endometrial remodelingQ45173635
Cortisol inactivation by 11beta-hydroxysteroid dehydrogenase-2 may enhance endometrial angiogenesis via reduced thrombospondin-1 in heavy menstruationQ46154195
P433issue8
P304page(s)702-712
P577publication date2011-08-01
P1433published inReproductive SciencesQ7314305
P1476titleSex steroid hormones and reproductive disorders: impact on women's health
P478volume18